Tumor gene expression patterns affecting response to BCl-2 inhibitor venetoclax in acute myeloid leukemia

被引：0
|
作者：
Garay, Juan Antonio Raygoza
Yun, Seongseok
Osman, Afaf
Ramlal, Reshma
Feith, David
Churchman, Michelle
Dhakal, Prajwal
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-5852
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5852
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The relevance of the BCL-2 gene and Wilm's tumor gene for the long-term prognosis of acute myeloid leukemia
    Bergmann, L
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1 - 1
  • [22] Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
    Wei, Yunxiong
    Cao, Yaqing
    Sun, Rui
    Cheng, Lin
    Xiong, Xia
    Jin, Xin
    He, Xiaoyuan
    Lu, Wenyi
    Zhao, Mingfeng
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [23] BCL-2 inhibition in Acute Myeloid Leukemia (AML)
    Konopleva, Marina
    Daver, Naval
    DiNardo, Courtney
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S9 - S10
  • [24] Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemia
    Lewis, Alexander C.
    Pope, Victoria S.
    Tea, Melinda N.
    Li, Manjun
    Nwosu, Gus O.
    Nguyen, Thao M.
    Wallington-Beddoe, Craig T.
    Moretti, Paul A. B.
    Anderson, Dovile
    Creek, Darren J.
    Costabile, Maurizio
    Ali, Saira R.
    Thompson-Peach, Chloe A. L.
    Dredge, B. Kate
    Bert, Andrew G.
    Goodall, Gregory J.
    Ekert, Paul G.
    Brown, Anna L.
    D'Andrea, Richard
    Robinson, Nirmal
    Pitman, Melissa R.
    Thomas, Daniel
    Ross, David M.
    Gliddon, Briony L.
    Powell, Jason A.
    Pitson, Stuart M.
    BLOOD, 2022, 139 (26) : 3737 - 3751
  • [25] Targeted therapy with a selective BCL-2 inhibitor in older patients with acute myeloid leukemia
    Campos, Elisabete do Vale
    Pinto, Ricardo
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2019, 41 (02) : 169 - 177
  • [26] The relationship between bcl-2 expression and response to chemotherapy in acute leukemia
    Maung, ZT
    Maclean, FR
    Reid, MM
    Pearson, ADJ
    Proctor, SJ
    Hamilton, PJ
    Hall, AG
    DRUG RESISTANCE IN LEUKEMIA AND LYMPHOMA II, 1997, 3 : 115 - 121
  • [27] First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia
    Boidol, Bernd
    Kornauth, Christoph
    van der Kouwe, Emiel
    Prutsch, Nicole
    Kazianka, Lukas
    Gultekin, Sinan
    Hoermann, Gregor
    Mayerhoefer, Marius E.
    Hopfinger, Georg
    Hauswirth, Alexander
    Panny, Michael
    Aretin, Marie-Bernadette
    Hilgarth, Bernadette
    Sperr, Wolfgang R.
    Valent, Peter
    Simonitsch-Klupp, Ingrid
    Moriggl, Richard
    Merkel, Olaf
    Kenner, Lukas
    Jaeger, Ulrich
    Kubicek, Stefan
    Staber, Philipp B.
    BLOOD, 2017, 130 (23) : 2499 - 2503
  • [28] Prescription patterns of venetoclax in acute myeloid leukemia
    Ucciero, Andrealuna
    Traversa, Giuseppe
    Pisterna, Alessia
    Cardinali, Valeria
    Sciabolacci, Sofia
    Poloni, Antonella
    Capelli, Debora
    Gaidano, Gianluca
    Patriarca, Andrea
    Lunghi, Monia
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (04)
  • [29] Venetoclax, the First BCL-2 Inhibitor for Use in Patients With Chronic Lymphocytic Leukemia
    Seymour, John
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (08) : 440 - 443
  • [30] Human A1 expression in acute myeloid leukemia and its relationship to bcl-2 expression
    Moreb, JS
    Zucali, J
    BLOOD, 2001, 97 (02) : 578 - 578
12345